COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 192

Article download: 106

IP Indian Journal of Immunology and Respiratory Medicine

High compliance of six-month INH preventive therapy in HIV patients: A stepping stone for the future

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Gyanshankar Mishra*

Volume : 4, Issue : 3, Year : 2019

Article Page : 161-163

Suggest article by email


Introduction: Tuberculosis (TB) continues to be the leading cause of morbidity and mortality among human immunodeficiency virus (HIV) infected individuals. Isoniazid preventive therapy (IPT) is one of the widely recommended interventions aimed to reduce the burden of TB (Tuberculosis) in people living with HIV. 
Methodology: A Retrospective analysis from clinical records, of all diagnosed HIV patients registered at ART (Anti-Retroviral Therapy) center of a tertiary care health institute) & initiated on six-month IPT (INH Preventive Therapy) during the period of November 2017 to December 2018 was conducted.
Results: A total of 575 HIV patients (554 (96%) adults and 21(4%) pediatric patients) were initiated on six-month IPT. These included 298 (52%) males and 277 (48%) female patients. 435 (76%) patients completed full six months of therapy. 15(2%) stopped treatment prior to completion of six months. 120(21%) patients were on regular therapy at the time of study. 5 patients were taking the IPT irregularly at the time of study. Among the 15 HIV patients who stopped IPT prior to completion of therapy duration, reasons for stopping IPT were adverse drug reactions (ADRs) in 8(53 %) patients, refusal in 4 (27%) patients and increased pill burden in 3 (20%) patients. The compliance rate of IPT in HIV patients was 97%.
Discussion: IPT Compliance is a potentially important factor in the disease course of HIV and hence an important determinant of survival rates in these patients. Appropriate monitoring and counselling may further increase the compliance rate of IPT among HIV patients.
Conclusion: HIV patients initiated on IPT have a good compliance rate for completion of regular six-month IPT.

Keywords: Human immunodeficiency; HIV; TB.

Doi : 10.18231/j.ijirm.2019.036

How to cite : Mishra G, High compliance of six-month INH preventive therapy in HIV patients: A stepping stone for the future. IP Indian J Immunol Respir Med 2019;4(3):161-163

Copyright © 2019 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (